HLA-C and cancer: In our interactions with cancer immunologists and clinicians, it was pointed out that immunoinformatics tools to predict MHC binding and antigen-processing are not user-friendly, as they often require elaborate pre- and post-processing of input and output data to make them applicable in the cancer setting.